Treat severe cases of infection at COV with XAV-19

This is letter of Intend to address the COVID-19 request by the European Union for the EIC accelerator. We have unique platform to develop polyclonal antibodies to address complex immune response such as the current pandemic. Over the course of the last 4 years we have developed pipeline of unique immunotherapies addressing various health needs, from transplantation to infectious disease. The coronavirus epidemic was developing we explored the possibility of developing treatment. Unfortunately given the time constraint and short notice we do not have the time to fully develop complete application we are submitting our response the current health need. We like the opportunity to further developed our plan with more time.